|
POFUT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.977700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.660290E-02 |
| Normal-vs-Stage2 |
9.600300E-02 |
| Normal-vs-Stage3 |
3.075100E-03 |
| Normal-vs-Stage4 |
1.485580E-01 |
| Stage1-vs-Stage2 |
6.731800E-01 |
| Stage1-vs-Stage3 |
1.803640E-01 |
| Stage1-vs-Stage4 |
9.448200E-01 |
| Stage2-vs-Stage3 |
6.577800E-01 |
| Stage2-vs-Stage4 |
6.922800E-01 |
| Stage3-vs-Stage4 |
3.157800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.879800E-03 |
| Normal-vs-AfricanAmerican |
2.191600E-02 |
| Normal-vs-Asian |
5.640600E-01 |
| Caucasian-vs-AfricanAmerican |
6.177000E-01 |
| Caucasian-vs-Asian |
7.476200E-01 |
| AfricanAmerican-vs-Asian |
5.692800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.560400E-03 |
| Normal-vs-Female |
9.897800E-03 |
| Male-vs-Female |
9.917000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.849200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.460100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.440300E-03 |
| Normal-vs-Age(81-100Yrs) |
6.533900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.375800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.146800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.367000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.847400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.758000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.007600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.954400E-01 |
| Normal-vs-Grade 2 |
2.935700E-03 |
| Normal-vs-Grade 3 |
4.639800E-03 |
| Normal-vs-Grade 4 |
4.701900E-02 |
| Grade 1-vs-Grade 2 |
2.558400E-01 |
| Grade 1-vs-Grade 3 |
1.441570E-01 |
| Grade 1-vs-Grade 4 |
2.079800E-01 |
| Grade 2-vs-Grade 3 |
8.538600E-01 |
| Grade 2-vs-Grade 4 |
9.610600E-01 |
| Grade 3-vs-Grade 4 |
9.423400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.210300E-04 |
| Normal-vs-ccB subtype |
4.671400E-01 |
| ccA subtype-vs-ccB subtype |
2.220000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.935300E-03 |
| Normal-vs-N1 |
8.619200E-01 |
| N0-vs-N1 |
2.359000E-01 |
|
|
